Clinical Trial Update: Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy [NA]

View source ↗

Summary

This clinical trial update discusses evaluating the Absnow II absorbable atrial septal defect closure system for closing atrial septal defects, with the trial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• Absnow II Absorbable Atrial Septal Defect Closure System

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Septal Defect | NA | Status: NOT_YET_RECRUITING